John Robert Pollard
ORCID:0009-0001-7995-9606
发表论文 159 篇 · 总被引 16295 次 · h-index 46
代表论文
- Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors (2020 · Journal of Clinical Oncology · 被引 257)
- Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial (2019 · The Lancet Neurology · 被引 230)
- Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours (2021 · British Journal of Cancer · 被引 128)
- Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours (2021 · British Journal of Cancer · 被引 104)
- Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study (2020 · Pediatric Neurology · 被引 63)
- Rational Design of 5-(4-(Isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine (VX-970, M6620): Optimization of Intra- and Intermolecular Polar Interactions of a New Ataxia Telangiectasia Mutated and Rad3-Related (ATR) Kinase Inhibitor (2019 · Journal of Medicinal Chemistry · 被引 56)